Literature DB >> 22234566

[Primary and secondary cardiovascular prevention results in patients with stroke: relapse risk and associated survival (Ebrictus study)].

Josep Ll Clua-Espuny1, Josep Ll Piñol-Moreso, Vicente F Gil-Guillén, Domingo Orozco-Beltrán, Anna Panisello-Tafalla, Jorgina Lucas-Noll, M Lluïssa Queralt-Tomás, Roger Pla-Farnós.   

Abstract

INTRODUCTION: The prevalence and cardiovascular risk factors control (CVRF) are determining to suffer a stroke and its relapse which arise the mortality and disability. AIM: To estimate the incidence of the first episode of ictus and describe the results in primary and secondary cardiovascular prevention. PATIENTS AND METHODS: Observational and prospective study of a fix cohort of 130,649 people, 15-90-year-old assigned to participants centers between 01/04/2006 and 31/03/2008. Community based register. Analyses were performed with the use of time-to-event methods, included Cox's multivariate on survival, risk of it's relapse; the CVRF diagnosed and it's relative risk (RR); cardiovascular risk.
RESULTS: 553 patients were enrolled (48,8% female), average age 73.3 ± 11.6 years with the first episode of stroke. After the episode, the hypertension (74.9% vs 88.7%), atrial fibrillation (9.9% vs 16%) and dislipemia (37.8% vs 49.8%) increased significantly as well its control. The 47% (95% CI = 42.8-51.2) of the cases had high risk of relapsing. In the 15.7% of the patients happened relapse of cardiovascular event, 48.3% of which were stroke. The main predictors variables were history of recurrent cardiovascular event (RR = 6.7; 95% CI = 2.2-21.7) and the aging (RR = 1,08; 95% CI = 1.01-1.2).
CONCLUSION: The cardiovascular secondary prevention seems to be more effective both in CVRF's detection and its control and is extremely important to get better results of survival.

Entities:  

Mesh:

Year:  2012        PMID: 22234566

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  4 in total

1.  Risk of Atrial Fibrillation, Ischemic Stroke and Cognitive Impairment: Study of a Population Cohort ≥65 Years of Age.

Authors:  Jose-Luis Clua-Espuny; Eulalia Muria-Subirats; Juan Ballesta-Ors; Blanca Lorman-Carbo; Josep Clua-Queralt; Elena Palà; Iñigo Lechuga-Duran; Delicia Gentille-Lorente; Alejandro Bustamante; Miguel Ángel Muñoz; Joan Montaner
Journal:  Vasc Health Risk Manag       Date:  2020-10-28

2.  [Compliance with recommendations in secondary prevention of stroke in primary care].

Authors:  Carmen Tamayo-Ojeda; Neus Parellada-Esquius; Betlem Salvador-González; Pilar Ángeles Oriol-Torón; M Dolores Rodríguez-Garrido; Dolores Muñoz-Segura
Journal:  Aten Primaria       Date:  2017-04-07       Impact factor: 1.137

Review 3.  Prevalence, Treatment, and Control of Hypercholesterolemia in High Cardiovascular Risk Patients: Evidences from a Systematic Literature Review in Spain.

Authors:  Alex de la Sierra; Xavier Pintó; Carlos Guijarro; José López Miranda; Daniel Callejo; Jesús Cuervo; Rudi Subirà; Marta Rubio
Journal:  Adv Ther       Date:  2015-10-26       Impact factor: 3.845

4.  Sex Differences in Long-Term Survival after a First Stroke with Intravenous Thrombolysis: Ebrictus Study.

Authors:  José Luis Clua-Espuny; Rosa Ripolles-Vicente; Teresa Forcadell-Arenas; Vicente Francisco Gil-Guillen; Maria Lluïsa Queralt-Tomas; María Antonia González-Henares; Anna Panisello-Tafalla; Carlos López-Pablo; Jorgina Lucas-Noll
Journal:  Cerebrovasc Dis Extra       Date:  2015-10-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.